Utility of ischemia modified albumin as an early marker for diagnosis of acute coronary syndrome

B Mishra, S Pandey, SR Niraula, BK Rai, P Karki… - 2018 - elibrary.nhrc.gov.np
Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …
被引用次数：29 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome

B Mishra, S Pandey, SR Niraula, BK Rai, P Karki… - pdfs.semanticscholar.org
Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …

Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome

B Mishra, S Pandey, SR Niraula, BK Rai… - Journal of Nepal Health …, 2018 - nepjol.info
Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …

Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome.

B Mishra, S Pandey, SR Niraula, BK Rai… - Journal of Nepal …, 2018 - europepmc.org
BACKGROUND: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …
[PDF] archive.org

[PDF][PDF] Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome

B Mishra, S Pandey, SR Niraula, BK Rai, P Karki… - scholar.archive.org
Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …
[PDF] academia.edu

[PDF][PDF] Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome

B Mishra, S Pandey, SR Niraula, BK Rai, P Karki… - academia.edu
Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …

Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome

B Mishra, S Pandey, SR Niraula… - Journal of Nepal …, 2018 - pubmed.ncbi.nlm.nih.gov
Background The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …
[PDF] archive.org

[PDF][PDF] Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome

B Mishra, S Pandey, SR Niraula, BK Rai, P Karki… - scholar.archive.org
Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …
[PDF] nepjol.info

[PDF][PDF] Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome

B Mishra, S Pandey, SR Niraula, BK Rai, P Karki… - nepjol.info
Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …

[引用][C] Utility of Ischemia Modified Albumin as an Early Marker for Diagnosis of Acute Coronary Syndrome

B Mishra, S Pandey, SR Niraula, BK Rai, P Karki… - Journal of Nepal Health …, 2018